← Open Payments lookup

AMEISHA SCOTT: Open Payments

NPI 1851609028 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,335 in 58 payments from 11 companies in 2025. Trend: 2023 $878 · 2024 $1,179 · 2025 $1,335

Food & beverage: $1,114Education: $221
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$403
Neurocrine BioSciences, Inc.13$254
Otsuka America Pharmaceutical, Inc.11$188
Alkermes, Inc.8$180
Lundbeck LLC3$68
Axsome Therapeutics, Inc.3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
E.R. Squibb & Sons, L.L.C.2$44
ABBVIE INC.2$37
Vanda Pharmaceuticals Inc.2$36

Products named: INGREZZA, ARISTADA, REXULTI, AUSTEDO XR, UZEDY, ABILIFY ASIMTUFII, Auvelity, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.